Sheppard v. Korus

CourtDistrict Court, E.D. Wisconsin
DecidedJune 3, 2024
Docket2:22-cv-00902
StatusUnknown

This text of Sheppard v. Korus (Sheppard v. Korus) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sheppard v. Korus, (E.D. Wis. 2024).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN

CHARLES SHEPPARD,

Plaintiff,

v. Case No. 22-cv-0902-bhl

JASMINE KORUS, et al.,

Defendants.

DECISION AND ORDER

Plaintiff Charles Sheppard, an inmate at New Lisbon Correctional Institution, is representing himself in this 42 U.S.C. §1983 action. He is proceeding on Eighth Amendment claims in connection with Defendants’ alleged deliberate indifference to (1) withdrawal symptoms he claims to have suffered after his medication was abruptly cancelled, (2) his threats of self-harm, and (3) the conditions of his confinement. On January 26, 2024, the State-employed Defendants and Defendant Christa Pierce separately moved for summary judgment.1 For the reasons explained below, the Court will grant Pierce’s summary judgment motion in its entirety and the State Defendants’ motion only in part. BACKGROUND At the relevant time, Sheppard was incarcerated at Fox Lake Correctional Institution, where Candace Whitman worked as the health services manager, Kristine DeYoung worked as a nurse, and Phillip Briski, Charles Congleton, Jr., Andrew Lyga, Matthew Larson, Jordan

1 Pierce’s motion did not comply with Civil L. R. 56(b)(1) in that she did not file a statement of proposed material facts as to which she contends there is no genuine issue and that entitle her to judgment as a matter of law. The Court will overlook this deficiency because she also joined the State Defendants’ summary judgment motion, which complied with the local rules. Wierenga, Carly Sandke, Scott Ross, Dana Miller, and Jasmine Korus worked as corrections staff. Also at the relevant time, Dr. Jeff Anders worked for the Wisconsin Department of Corrections Bureau of Health Services as the Psychiatry Director, and Pierce worked as a nurse practitioner who contracted with the Department of Corrections. Dkt. Nos. 73, 87 at ¶¶1-13; Dkt. No. 85 at 2.

1. The Discontinuation of Sheppard’s Bupropion. In the fall of 2019, Sheppard was taking bupropion, an antidepressant used to treat depression. On September 28, 2019, during a cell search, nine pills were found on a shelf in Sheppard’s cell, two of which were identified as bupropion. Sheppard received a conduct report and was later found guilty of misusing bupropion. On October 7, 2019, Whitman noted Sheppard’s misuse of bupropion in his chart and forwarded a note on the misuse to Pierce. Pierce reviewed Whitman’s note on October 18, 2019, and in accordance with prison policy, discontinued Sheppard’s prescription due to the misuse. The next day, on October 19, 2022, Sheppard submitted a health services request in which he stated that withdrawal symptoms were beginning and complained he was having “debilitating headaches.” Dkt. Nos. 73, 87 at ¶¶20-21; Dkt. No. 75-2

at 22. On October 20, 2019, Nurse DeYoung received a call from a restrictive housing unit officer reporting that Sheppard had been vomiting. DeYoung spoke to Sheppard who told her that he had vomited twice in the last hour. Sheppard also stated that he believed he was having increased irritability because the bupropion had been suddenly discontinued. DeYoung checked in with Sheppard again later that afternoon. The parties offer differing reports on this conversation. According to DeYoung, Sheppard told her his symptoms were resolved, so she ordered him a liter of Gatorade and a bagged lunch. Sheppard, on the other hand, insists he told DeYoung his symptoms had gotten worse. He asserts that he told her he was in extreme pain, was continuously vomiting, had stomach cramps, was profusely sweating, and had defecated on himself. Dkt. Nos. 73, 87 at ¶¶24-24. The following day, on October 21, 2019, Sheppard submitted a health services request stating that his withdrawal symptoms were worse and that he was having a hard time breathing.

He asked to be restarted on bupropion. Whitman reviewed the request and called Pierce, who informed Whitman that withdrawal from bupropion is unlikely and that any symptoms should resolve quickly. Pierce advised Whitman that Sheppard’s bupropion would not be restarted. The next day, on October 22, 2019, Whitman responded to Sheppard and informed him that she had spoken to his psychiatrist and that it was unlikely that his symptoms were related to the discontinuation of the bupropion. Dkt. Nos. 73, 87 at ¶¶25-30; Dkt. No. 75-2 at 23. On October 25, 2019, Sheppard met with Pierce and informed her of his history of withdrawal symptoms when his bupropion had been cancelled. Pierce responded by re-prescribing Sheppard’s bupropion. It is not clear why, but the medication was not given to Sheppard at that time. A few days later, on October 28, 2019, Pierce, Dr. Anders, and Whitman discussed

Sheppard’s case via email. Specifically, Pierce informed Dr. Anders that Sheppard had presented her with court documents and a psychiatric evaluation stating that bupropion was used to treat Sheppard’s depression. She advised Dr. Anders that Sheppard had filed lawsuits in the past when his medication had been abruptly cancelled. She also informed him that she had adjusted Sheppard’s prescription, and she asked for guidance on when to stop or taper medication in the event it is misused by an inmate. Dr. Anders responded that bupropion should be stopped per policy after misuse, even if an outside psychiatrist supports the medication and even if the inmate threatens legal action. Dr. Anders also explained that, if there is a documented history of withdrawal symptoms, a taper could be ordered for a few extra days or up to a week at most. Finally, Dr. Anders informed Pierce that for him to even consider approving bupropion, he would need clear evidence that Sheppard has had severe unremitting symptoms that responded only to bupropion after adequate trials of other medications. Dr. Anders suggested several other antidepressants Pierce could prescribe instead.

Dkt. Nos. 73, 87 at ¶¶31-38. Defendants explain that withdrawal symptoms with bupropion are not common. Those who do experience withdrawal may become irritated or agitated. Defendants also explain that bupropion has a high risk of misuse in a corrections environment, so it is very restricted. They note that there is a security concern that inmates may sell, barter, or even blackmail other inmates with it. Moreover, because bupropion has a higher chance of inducing seizures than other antidepressants, misuse of the medication poses a significant risk to inmates who have not been prescribed the medication. Dkt. Nos. 73, 87 at ¶¶34, 36, 39-41. Pierce informed Dr. Anders that she would start a taper on November 1, 2019, but Whitman noted that Sheppard’s prescription had not been restarted when she reordered it on October 25,

2019, and Sheppard had now been off the medication for more than a week. With these considerations in mind, Dr. Anders instructed Whitman not to restart the bupropion unless Sheppard was still experiencing significant withdrawal symptoms. Dr. Anders advised that Sheppard should consult with Pierce soon to discuss alternative medication options. Pierce reminded Dr. Anders that the psychiatric assessment Sheppard had shown her said he should be tapered off bupropion over the course of a month. But she clarified that Sheppard was doing fine and looked fine. Whitman expressed her belief that it would only make the situation worse if they restarted bupropion since he had been off it for over a week and, apart from the first couple days, had been fine. Dr. Anders, Pierce, and Whitman agreed that Sheppard would not be allowed to restart bupropion. Dkt. Nos. 73, 87 at ¶¶41-48. 2. Sheppard’s Attempt at Self-Harm.2 Months later, at about 10 p.m. on December 24, 2019, DeYoung received a call from the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rhodes v. Chapman
452 U.S. 337 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Siegel v. Shell Oil Co.
612 F.3d 932 (Seventh Circuit, 2010)
Timothy Parent v. Home Depot U.S.A.
694 F.3d 919 (Seventh Circuit, 2012)
Shane Holloway v. Delaware County S
700 F.3d 1063 (Seventh Circuit, 2012)
George v. Smith
507 F.3d 605 (Seventh Circuit, 2007)
Christopher Pyles v. Magid Fahim
771 F.3d 403 (Seventh Circuit, 2014)
Miguel Perez v. James Fenoglio
792 F.3d 768 (Seventh Circuit, 2015)
Marcos Gray v. Marcus Hardy
826 F.3d 1000 (Seventh Circuit, 2016)
Jeremy Lockett v. Tanya Bonson
937 F.3d 1016 (Seventh Circuit, 2019)
Levi A. Lord v. Joseph Beahm
952 F.3d 902 (Seventh Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
Sheppard v. Korus, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sheppard-v-korus-wied-2024.